JPRN-UMIN000051344招募中Unknown
The efficacy and safety of Tirzepatide for type 2 diabetes subjects with chronic kidney disease: prospective observational study - Kushiro T2DCKD-TZP study
Kushiro Red Cross Hospital0 个研究点目标入组 50 人开始时间: 2023年6月16日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Subjects on erythropoietin stimulating agents or hypoxia-inducible factor-prolyl hydroxylase domain inhibitor 2) Subjects on maintenance hemodialysis or peritoneal dialysis 3) Subjects who are deemed to be unsuitable by the investigator
研究者
相似试验
招募中
Unknown
A Study on the Safety and Efficacy of Tirzepatide in People with Type 2 DiabetesType 2 DiabetesJPRN-UMIN000052214Kitasato University50
尚未招募
2 期
Tirzepatide in kidney transplant candidates: a pilot studyEnd-stage renal diseaseRenal and Urogenital - Kidney diseaseMetabolic and Endocrine - Metabolic disordersObesityACTRN12624000665538St Vincent's Hospital Melbourne8
招募中
Unknown
Clinical Study on the Efficacy of Tirzepatide for Diabetes Complicated ObesityJPRN-UMIN000054143Sekino Hospital10
进行中（未招募）
4 期
A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 DiabetesType 2 DiabetesNCT05433584Eli Lilly and Company780
招募中
Unknown
The renal benefits of Tirzepatide for type 2 diabetes subjects with chronic kidney disease: prospective observational studyType 2 diabetesJPRN-UMIN000051442Kushiro Red Cross Hospital50